Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019

SELL
$0.98 - $1.85 $1,470 - $2,775
-1,500 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$1.76 - $6.38 $2,640 - $9,570
-1,500 Reduced 50.0%
1,500 $3,000
Q2 2018

Aug 14, 2018

SELL
$3.29 - $4.82 $37,177 - $54,466
-11,300 Reduced 79.02%
3,000 $10,000
Q1 2018

May 14, 2018

BUY
$1.81 - $5.98 $25,883 - $85,514
14,300 New
14,300 $57,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $967M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.